Levetiracetam Aristo

Levetiracetam, the active ingredient in Levetiracetam Aristo, is an Anticonvulsant presented as an oral tablet for oral use. It treats partial‑onset, myoclonic, and primary generalized tonic‑clonic seizures in patients who require seizure control.

GNH USA supplies Levetiracetam Aristo as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic drug used to manage several seizure types. - Partial‑onset seizures: reduces seizure frequency in focal epilepsy. - Myoclonic seizures: diminishes sudden muscle jerks in patients with myoclonic epilepsy. - Primary generalized tonic‑clonic seizures: helps prevent generalized convulsive episodes.

Levetiracetam may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Dizziness: sensation of light‑headedness or unsteadiness. - Fatigue: persistent tiredness not relieved by rest. - Headache: mild to moderate cranial pain. - Irritability: mood changes or increased agitation. - Nausea: upset stomach or urge to vomit. - Nasal congestion: blocked or runny nose.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Mood disorders: depression or suicidal thoughts. - Blood abnormalities: reduced white blood cells or platelets. - Hepatic dysfunction: elevated liver enzymes. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis.

Before initiating therapy, consider the following safety measures. - Renal function: adjust dose in patients with impaired kidney function. - Psychiatric history: monitor for mood changes or suicidal ideation. - Concomitant CNS depressants: assess additive sedation risk. - Pregnancy and lactation: evaluate benefit‑risk ratio with a healthcare professional. - Elderly patients: start with lower doses and titrate cautiously. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Levetiracetam can interact with other medicines, influencing efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: may reduce levetiracetam plasma levels. - Phenobarbital: may decrease levetiracetam exposure.

Moderate Interactions (Monitor Closely): - Alcohol: increased sedation and dizziness. - Other antiepileptics (e.g., valproate): potential additive CNS effects. - Oral contraceptives: limited data, monitor for reduced contraceptive effectiveness.